Title : Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies.

Pub. Date : 2019

PMID : 30705592






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Due to ponatinib"s unique multi-targeted characteristics, further studies have demonstrated its ability to target other important tyrosine kinases (FGFR, PDGFR, SRC, RET, KIT, and FLT1) in other human malignancies. ponatinib ret proto-oncogene Homo sapiens